THG Plunges 7% as Hopes on 20 Million Doses of Pfizer Covid-19 Vaccine Slip

The share price of Thonburi Healthcare Group Public Company Limited (THG) plunged ฿2.25/share or 7.32% to ฿28.50/share with a trading value of 99.8 million baht as of 11:09 local time in Thailand.

 

The decline came after the interview of Mr. Boon Vanasin, Chairman of the Board of Directors, this morning with Inside Thailand program, saying that the deal for 20 million doses of Pfizer Covid-19 vaccine has a high probability of not succeeding due to many obstacles in the negotiation for imports.

“There is a 90% chance that the vaccine will not be coming,” said Mr. Vanasin through the program.

“We lost 500-600 million baht on the deposit to the agencies that procure vaccines for us,” he added.

 

When asked which manufacturer the company dealt with in the purchasing of Covid-19 vaccine, the Chairman stated that the vaccines are special quotas from many Pfizer and BioNTech manufacturers around the world in which the agencies can procure only a small portion from each manufacturer.

However, due to obstacles in finding an importer for the vaccine, the company had lost 500-600 million baht in deposit, while the probability of acquiring 20 million doses is very low to the point that there is 90% chance that the vaccine will not be coming, according to the interview.